Skip to content
  • Clinical Studies
  • Pharma Tips
  • Pharma GMP
  • Pharma SOP
  • Pharma Books
  • Schedule M
StabilityStudies.in

StabilityStudies.in

Pharma Stability: Insights, Guidelines, and Expertise

Tag: Drug stability studies,

How to Address Stability Testing Requirements for Investigational New Drug (IND) Applications

Posted on By

How to Address Stability Testing Requirements for Investigational New Drug (IND) Applications Meeting Stability Testing Requirements for IND Applications: A Detailed Guide Introduction Stability testing is a crucial component of Investigational New Drug (IND) applications, ensuring that investigational products remain safe and effective throughout clinical trials. Understanding and meeting the stability testing requirements set by…

Read More “How to Address Stability Testing Requirements for Investigational New Drug (IND) Applications” »

'How to' - Stability Studies

How to Conduct Stability Studies for Topical Products in Compliance with US FDA and EMA Guidelines

Posted on By

How to Conduct Stability Studies for Topical Products in Compliance with US FDA and EMA Guidelines Conducting Stability Studies for Topical Products: US FDA and EMA Compliance Introduction Topical products, such as creams, ointments, and lotions, require specific stability studies to ensure their safety and efficacy over time. Compliance with US FDA and EMA guidelines…

Read More “How to Conduct Stability Studies for Topical Products in Compliance with US FDA and EMA Guidelines” »

'How to' - Stability Studies

How to Implement ICH Q9 for Risk Management in Stability Testing

Posted on By

How to Implement ICH Q9 for Risk Management in Stability Testing Applying ICH Q9 Principles for Effective Risk Management in Stability Testing Introduction ICH Q9 provides a systematic approach to risk management in the pharmaceutical industry, including stability testing. Effective implementation of ICH Q9 ensures that risks associated with stability testing are identified, evaluated, and…

Read More “How to Implement ICH Q9 for Risk Management in Stability Testing” »

'How to' - Stability Studies

How to Conduct Stability Studies for Fixed-Dose Combination Products under Regulatory Guidelines

Posted on By

How to Conduct Stability Studies for Fixed-Dose Combination Products under Regulatory Guidelines Conducting Stability Studies for Fixed-Dose Combination Drugs: A Regulatory Approach Introduction Fixed-dose combination (FDC) products combine two or more active pharmaceutical ingredients (APIs) in a single dosage form. Conducting stability studies for these products is crucial to ensure their safety, efficacy, and quality…

Read More “How to Conduct Stability Studies for Fixed-Dose Combination Products under Regulatory Guidelines” »

'How to' - Stability Studies

How to Ensure Compliance with Global Stability Testing Requirements (US FDA, EMA, WHO)

Posted on By

How to Ensure Compliance with Global Stability Testing Requirements (US FDA, EMA, WHO) Ensuring Compliance with International Stability Testing Standards: A Comprehensive Guide Introduction Stability testing is a critical aspect of pharmaceutical development and quality assurance. Ensuring compliance with global stability testing requirements is essential for the approval, distribution, and maintenance of drug products in…

Read More “How to Ensure Compliance with Global Stability Testing Requirements (US FDA, EMA, WHO)” »

'How to' - Stability Studies

Guide to Conducting Stability Studies on Pharmaceutical Dosage Forms

Posted on By

Follow these instructions to conduct stability studies effectively on various pharmaceutical dosage forms: General Considerations: For each dosage form: Evaluate appearance, assay, and degradation products. Limit degradation product testing for generic products to compendial requirements. Note: The listed tests are not exhaustive. Not every test needs to be included in the stability protocol. Consider safety…

Read More “Guide to Conducting Stability Studies on Pharmaceutical Dosage Forms” »

Stability Studies Blog

Stability Studies for Drugs with Low Solubility

Posted on By

Drugs with low solubility present unique challenges in stability studies due to their limited aqueous solubility, which can affect dissolution, bioavailability, and stability under various storage conditions. Conducting stability studies for such drugs requires careful consideration of formulation strategies, analytical methods, and regulatory requirements to ensure accurate assessment of product stability and shelf life. Key…

Read More “Stability Studies for Drugs with Low Solubility” »

Stability Studies Blog

Regulatory requirements for stability studies

Posted on By

Regulatory Requirements for Stability Studies in Different Regions Stability studies are an integral part of the drug development process, ensuring the safety, efficacy, and quality of pharmaceutical products throughout their shelf life. Regulatory agencies in different regions, including the United States, Europe, and other countries, have established guidelines and requirements for conducting stability studies to…

Read More “Regulatory requirements for stability studies” »

Stability Studies Blog

Stability Studies for Peptides and Proteins

Posted on By

Peptides and proteins are biopharmaceuticals with complex structures and delicate chemical properties. Stability studies for peptides and proteins are crucial for assessing their physical, chemical, and biological stability under various storage conditions. These studies provide valuable insights into the degradation pathways, formulation optimization, and shelf-life determination of peptide and protein-based therapeutics. Key Considerations When conducting…

Read More “Stability Studies for Peptides and Proteins” »

Stability Studies Blog

Conducting stability studies for complex dosage Forms

Posted on By

Considerations for Stability Studies of Complex Dosage Forms Complex dosage forms, such as extended-release formulations, liposomal formulations, and combination products, present unique challenges in stability studies due to their intricate compositions, varied release mechanisms, and susceptibility to degradation. Conducting stability studies for complex dosage forms requires careful consideration of formulation characteristics, manufacturing processes, and regulatory…

Read More “Conducting stability studies for complex dosage Forms” »

Stability Studies Blog

Posts pagination

Previous 1 … 32 33 34 … 50 Next

Quick Guide

  • Stability Tutorials
  • Stability Testing Types
    • Types of Stability Studies
    • Real-Time and Accelerated Stability Studies
    • Intermediate and Long-Term Stability Testing
    • Freeze-Thaw and Thermal Cycling Studies
    • Photostability and Oxidative Stability Studies
    • Stability Testing for Biopharmaceuticals
  • Stability Studies SOP
  • ‘How to’ – Stability Studies
  • Regulatory Guidelines
  • Shelf Life and Expiry Dating
  • Stability Documentation
  • Stability Studies – API
  • Stability Studies Blog
  • Stability Studies FAQ
  • Packaging – Containers – Closers
Widget Image
  • Maintain Backup Stability Chambers to Prevent Data Loss in Case of Failure

    Understanding the Tip: Why backup chambers are essential: Stability chambers are critical infrastructure in pharmaceutical QA.
    A sudden malfunction—due to power failure, temperature controller breakdown,… Read more

Copyright © 2025 StabilityStudies.in.

Powered by PressBook WordPress theme